🫀
Cardiac MRI Digests
Weekly AI-summarised digests of PubMed articles on cardiac MRI, CMR, and cardiovascular magnetic resonance.
74 digests total RSS feed →
69 art.
15 cat.
What's New in Cardiac MRI? — July 18, 2026
AI-summarised digest of 69 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI in Rare Congenital/Structural Heart Disease CMR Phenotyping in Obesity and Body Composition CMR in Hypertrophic Cardiomyopathy (HCM): Risk, Genotype, and Therapy CMR in Dilated/Inflammatory Cardiomyopathy and Myocarditis Sequelae CMR in Arrhythmias and Sudden Cardiac Death Risk (Including Athlete Cases) CMR in Cardiac Amyloidosis and Surrogates for Amyloid Burden +9 more
55 art.
15 cat.
What's New in Cardiac MRI? — July 16, 2026
AI-summarised digest of 55 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI (CMR) acquisition, reconstruction, and image quality CMR biomarkers for cardiac remodeling, fibrosis, and function CMR in cardiomyopathies and genetic heart disease (HCM, Fabry, etc.) Arrhythmia, sudden death risk, and rhythm monitoring Ischemia/reperfusion injury and acute coronary syndromes (biomarkers/imaging) Thrombus and embolic risk (CMR-detected) +9 more
56 art.
15 cat.
What's New in Cardiac MRI? — July 15, 2026
AI-summarised digest of 56 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI in Coronary Disease & Ischemia/Microvascular Dysfunction Cardiac MRI in Myocarditis & Inflammatory Cardiomyopathies Cardiac MRI in Pericarditis & Pericardial Inflammation Cardiac MRI in Heart Failure Risk, Screening & Prognosis Cardiac MRI in Hypertrophic Cardiomyopathy (HCM) Phenotyping & Risk Cardiac MRI in Atrial Fibrillation, Fibrosis & Ablation Outcomes +9 more
56 art.
15 cat.
What's New in Cardiac MRI? — July 14, 2026
AI-summarised digest of 56 PubMed articles on Cardiac MRI published in the last 7 days.
Myocardial viability & revascularization decision-making Hypertrophic cardiomyopathy (HCM) progression, risk, and phenotyping Atrial fibrillation (AF) mechanisms, fibrosis, and ablation substrate Myocarditis and transition to cardiomyopathy/heart failure Stress (Takotsubo) cardiomyopathy and other acute cardiomyopathy triggers Cardiac MRI (CMR) acquisition acceleration, motion robustness, and workflow standardization +9 more
59 art.
15 cat.
What's New in Cardiac MRI? — July 12, 2026
AI-summarised digest of 59 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI methods & quantitative imaging Echocardiography biomarkers & simple functional metrics Myocarditis: clinical features, imaging, and risk Pericarditis: diagnosis and anti-inflammatory therapies Ischemia/reperfusion injury & infarct microvascular damage biomarkers Acute coronary syndromes & infarct size/load-modifying strategies +9 more
58 art.
15 cat.
What's New in Cardiac MRI? — July 10, 2026
AI-summarised digest of 58 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI & Tissue Characterization Methods (CMR workflows, mapping, fibrosis quantification) Cardiac MRI for Ischemia, Microvascular Dysfunction, and Silent Infarction Myocarditis, Inflammatory Cardiomyopathies, and Arrhythmic Risk Hypereosinophilic Syndromes, Loeffler/Endomyocarditis, and Paraneoplastic Cardiac Disease Fabry Disease: Diagnosis, Biomarkers, and Cardiac Monitoring Hypertrophic Cardiomyopathy (HCM): Prognosis, Imaging Biomarkers, and Phenotyping +9 more
62 art.
15 cat.
What's New in Cardiac MRI? — July 09, 2026
AI-summarised digest of 62 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI & Tissue Characterization Methods Cardiac MRI for Ischemia, Infarction & Microvascular Injury Heart Failure (including HFpEF/HFrEF) Risk, Prevention & Cost/Access Arrhythmias & Electrophysiology (AF/VT/PVC/SCD) & Ablation Cardiomyopathies & Genetic/Inherited Heart Disease Inflammatory Myocardial Disease & Myocarditis/Sarcoidosis +9 more
93 art.
15 cat.
What's New in Cardiac MRI? — July 08, 2026
AI-summarised digest of 93 PubMed articles on Cardiac MRI published in the last 7 days.
Cardiac MRI biomarkers & tissue characterization (LGE/ECV/T1/T2/entropy/quantitative mapping) Cardiomyopathies & inherited/genetic heart disease (including genotype–phenotype divergence) Arrhythmias & sudden cardiac death risk (including ablation substrate and PVCs) Myocarditis & inflammatory cardiomyopathies (incl. myocarditis-like phenotypes) Takotsubo syndrome & stress cardiomyopathy phenotyping Ischemic heart disease, MINOCA/MINOCA-like syndromes & myocardial injury mechanisms +9 more